Indivior PLC (INDV) Financial Analysis & Valuation | Quarter Chart
Indivior PLC (INDV)
INDVPrice: $41.26
Fair Value: 🔒
🔒score
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographi... more
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and... more
Description
Shares
| Market Cap | $5.15B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Joseph J. Ciaffoni |
| IPO Date | 2014-12-29 | CAGR | 0.03% |
| Employees | 1,030 | Website | www.indivior.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.28% | Total Yield | 2.28% |
INDV chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.59B | P/E Ratio | 13.71 |
| Forward P/E | 9.96 | PEG Ratio | 0.26 |
| P/S Ratio | 4.27 | P/B Ratio | -38.47 |
| P/CF Ratio | -53.8 | P/FCF Ratio | -29.87 |
| EPS | $3.01 | EPS Growth 1Y | 1314.29% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 10.25% | Gross Margin | 0.83% |
| Operating Margin | 0.33% | Profit Margin | 0.19% |
| ROE | -1.42% | ROA | 0.21% |
| ROCE | 1.03% | Current Ratio | 0.86 |
| Quick Ratio | 0.66 | Cash Ratio | 0.22 |
| Debt/Equity | -3.53 | Interest Coverage | 10.75 |
| Altman Z Score | 4.13 | Piotroski Score | 4 |